Dabrafenib
From WikiLectures
Dabrafenib (sold under the brand name Tafinlar) is a serine/threonine kinase receptor inhibitor BRAF. It is approved for therapy of malignant melanoma with a proven mutation.
References[edit | edit source]
External Links[edit | edit source]
- European Medicines Agency. Souhnr údajů o přípravku Tafinlar 50 mg tobolky [online]. [cit. 12.3.2014]. < https://www.ema.europa.eu/en/documents/product-information/tafinlar-epar-product-information_cs.pdf >
